Publicaciones en colaboración con investigadores/as de University of California, San Francisco (5)

2021

  1. Treatment-Related Changes in Bone Turnover and Fracture Risk Reduction in Clinical Trials of Antiresorptive Drugs: Proportion of Treatment Effect Explained

    Journal of Bone and Mineral Research, Vol. 36, Núm. 2, pp. 236-243

2020

  1. Treatment-related changes in bone mineral density as a surrogate biomarker for fracture risk reduction: meta-regression analyses of individual patient data from multiple randomised controlled trials

    The Lancet Diabetes and Endocrinology, Vol. 8, Núm. 8, pp. 672-682

2019

  1. Change in Bone Density and Reduction in Fracture Risk: A Meta-Regression of Published Trials

    Journal of Bone and Mineral Research, Vol. 34, Núm. 4, pp. 632-642

  2. Reply to: Change in Bone Density and Reduction in Fracture Risk: A Meta-Regression of Published Trials

    Journal of Bone and Mineral Research

2017

  1. Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial

    The Lancet, Vol. 390, Núm. 10102, pp. 1585-1594